Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasma-FTK is a Russian biotechnology and medical device company specializing in the development and manufacturing of cold atmospheric plasma (CAP) systems for clinical applications. The company's flagship technology, the Helios system, utilizes ionized gas at room temperature to provide antimicrobial, anti-inflammatory, and regenerative effects on biological tissues. Their products are primarily indicated for the treatment of chronic non-healing wounds, such as diabetic foot ulcers and pressure sores, as well as for disinfecting surgical sites and treating various dermatological conditions. Plasma-FTK operates at the intersection of physics and medicine, providing non-pharmacological alternatives for managing antibiotic-resistant infections and accelerating tissue repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ПЛАЗМА-ФТК.